Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce body weight, glycaemia, blood pressure, postprandial lipaemia and infammation actions that could contribute to the reduction of cardiovascular events
The clinic specializes in peptide therapy alongside PRP, stem cell treatments, and hormone optimization
Illustratively, BPC 157 is very active in the rats with occluded superior sagittal sinus [20], as well as when given in the reperfusion in the rats with stroke, where BPC 157 therapy counteracted hippocampal ischemia/reperfusion injuries and functional and cognitive deficits [21]
Not every patient needs this treatment approach Noom-affiliated prescribers, at their discretion on a patients need, can also prescribe branded GLP-1 medications like Zepbound, oral medications like metformin, and alternate GLP-1 medications like liraglutide but for those who do it could mean all the difference